Display options
Cite
Omosa LK, Midiwo JO, Mbaveng AT, et al. Antibacterial activities and structure-activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes. Springerplus. 2016;5(1):901doi: 10.1186/s40064-016-2599-1.
Omosa, L. K., Midiwo, J. O., Mbaveng, A. T., Tankeo, S. B., Seukep, J. A., Voukeng, I. K., Dzotam, J. K., Isemeki, J., Derese, S., Omolle, R. A., Efferth, T., & Kuete, V. (2016). Antibacterial activities and structure-activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes. SpringerPlus, 5(1), 901. https://doi.org/10.1186/s40064-016-2599-1
Omosa, Leonidah K, et al. "Antibacterial activities and structure-activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes." SpringerPlus vol. 5,1 (2016): 901. doi: https://doi.org/10.1186/s40064-016-2599-1
Omosa LK, Midiwo JO, Mbaveng AT, Tankeo SB, Seukep JA, Voukeng IK, Dzotam JK, Isemeki J, Derese S, Omolle RA, Efferth T, Kuete V. Antibacterial activities and structure-activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes. Springerplus. 2016 Jun 27;5(1):901. doi: 10.1186/s40064-016-2599-1. eCollection 2016. PMID: 27386347; PMCID: PMC4923020.
Copy Download .nbib Format: NLM
Share it on

Springerplus. 2016 Jun 27;5(1):901. doi: 10.1186/s40064-016-2599-1. eCollection 2016.

Antibacterial activities and structure-activity relationships of a panel of 48 compounds from Kenyan plants against multidrug resistant phenotypes.

SpringerPlus

Leonidah K Omosa, Jacob O Midiwo, Armelle T Mbaveng, Simplice B Tankeo, Jackson A Seukep, Igor K Voukeng, Joachim K Dzotam, John Isemeki, Solomon Derese, Ruth A Omolle, Thomas Efferth, Victor Kuete

Affiliations

  1. Department of Chemistry, School of Physical Sciences, University of Nairobi, P. O. Box 30197-00100, Nairobi, Kenya ; Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.
  2. Department of Chemistry, School of Physical Sciences, University of Nairobi, P. O. Box 30197-00100, Nairobi, Kenya.
  3. Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, Cameroon.
  4. Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.

PMID: 27386347 PMCID: PMC4923020 DOI: 10.1186/s40064-016-2599-1

Abstract

In the current study forty eight compounds belonging to anthraquinones, naphthoquinones, benzoquinones, flavonoids (chalcones and polymethoxylated flavones) and diterpenoids (clerodanes and kauranes) were explored for their antimicrobial potential against a panel of sensitive and multi-drug resistant Gram-negative and Gram-positive bacteria. The minimal inhibitory concentration (MIC) determinations on the tested bacteria were conducted using modified rapid INT colorimetric assay. To evaluate the role of efflux pumps in the susceptibility of Gram-negative bacteria to the most active compounds, they were tested in the presence of phenylalanine arginine β-naphthylamide (PAβN) (at 30 µg/mL) against selected multidrug resistance (MDR) bacteria. The anthraquinone, emodin, naphthaquinone, plumbagin and the benzoquinone, rapanone were active against methicillin resistant Staphylococcus aureus (MRSA) strains of bacteria with MIC values ranging from 2 to 128 μg/mL. The structure activity relationships of benzoquinones against the MDR Gram-negative phenotype showed antibacterial activities increasing with increase in side chain length. In the chalcone series the presence of a hydroxyl group at C3' together with a methoxy group and a second hydroxyl group in meta orientation in ring B of the chalcone skeleton appeared to be necessary for minimal activities against MRSA. In most cases, the optimal potential of the active compounds were not attained as they were extruded by bacterial efflux pumps. However, the presence of the PAβN significantly increased the antibacterial activities of emodin against Gram-negative MDR E. coli AG102, 100ATet; K. pneumoniae KP55 and KP63 by >4-64 g/mL. The antibacterial activities were substantially enhanced and were higher than those of the standard drug, chloramphenicol. These data clearly demonstrate that the active compounds, having the necessary pharmacophores for antibacterial activities, including some quinones and chalcones are substrates of bacterial efflux pumps and therefore should be combined to efflux pump inhibitors in the fight against MDR bacterial infections.

Keywords: Anthraquinones; Antibacterial activities; Benzoquinones; Chalcones; Efflux pump inhibitor; Multidrug resistance

References

  1. J Ethnopharmacol. 2007 Oct 8;114(1):54-60 - PubMed
  2. Phytochemistry. 2003 Oct;64(4):855-62 - PubMed
  3. J Antimicrob Chemother. 1996 Mar;37(3):403-21 - PubMed
  4. Cell. 2007 Mar 23;128(6):1037-50 - PubMed
  5. Helv Chim Acta. 1948 Dec 1;31(7):2237-41 - PubMed
  6. Phytochemistry. 1996 Feb;41(3):795-9 - PubMed
  7. Farmaco. 2001 Jan-Feb;56(1-2):3-12 - PubMed
  8. Annu Rev Biochem. 2009;78:119-46 - PubMed
  9. Antimicrob Agents Chemother. 2005 Aug;49(8):3578-82 - PubMed
  10. Antimicrob Agents Chemother. 2002 Aug;46(8):2640-3 - PubMed
  11. Chem Pharm Bull (Tokyo). 1965 Apr;13:511-6 - PubMed
  12. Chem Pharm Bull (Tokyo). 1999 Aug;47(8):1121-7 - PubMed
  13. Planta Med. 2010 Oct;76(14):1479-91 - PubMed
  14. Nat Prod Commun. 2013 Feb;8(2):175-6 - PubMed
  15. Indian J Med Res. 1990 Jan;91:18-20 - PubMed
  16. Am J Chin Med. 1996;24(2):139-42 - PubMed
  17. Int J Antimicrob Agents. 2011 Feb;37(2):156-61 - PubMed
  18. Phytochemistry. 2006 Jul;67(13):1322-5 - PubMed
  19. Drug Discov Today. 2002 Nov 1;7(21):1086-91 - PubMed
  20. Phytochemistry. 2001 Jun;57(4):571-4 - PubMed
  21. J Pharm Pharmacol. 2001 Mar;53(3):283-94 - PubMed
  22. Planta Med. 1998 Dec;64(8):711-3 - PubMed
  23. Molecules. 2012 Jan 17;17(1):843-50 - PubMed
  24. Eur J Clin Microbiol Infect Dis. 1990 Jul;9(7):455-61 - PubMed
  25. Drug Discov Ther. 2013 Apr;7(2):66-72 - PubMed
  26. Antimicrob Agents Chemother. 2007 Mar;51(3):923-9 - PubMed
  27. J Ethnopharmacol. 2009 Jul 30;124(3):556-61 - PubMed
  28. Antimicrob Agents Chemother. 2009 May;53(5):2209-11 - PubMed
  29. Aust J Exp Biol Med Sci. 1955 Oct;33(5):547-54 - PubMed
  30. Clin Ther. 2003 May;25(5):1321-81 - PubMed
  31. Rev Inst Antibiot (Recife). 1974 Dec;14(1-2):9-16 - PubMed
  32. Curr Drug Targets. 2008 Sep;9(9):750-9 - PubMed
  33. Biochem Biophys Res Commun. 2005 Mar 25;328(4):1113-8 - PubMed
  34. Front Pharmacol. 2010 Oct 25;1:123 - PubMed
  35. Planta Med. 1984 Feb;50(1):111 - PubMed
  36. Biochem Biophys Res Commun. 2000 Aug 2;274(2):496-9 - PubMed
  37. J Agric Food Chem. 2003 Oct 22;51(22):6456-60 - PubMed

Publication Types